Health authorities in New Zealand, on Monday, reported one death linked to the Pfizer COVID-19 vaccine.
Reuters reported the country’s health ministry released information about the woman’s death after receiving the vaccine following a review by an independent COVID-19 vaccine safety monitoring board (CV-ISMB).
According to the statement released by the CV-ISMB, the woman was said to have died from myocarditis after taking the Pfizer vaccine.
The CV-ISMB also said the woman likely developed the condition because of the vaccine, adding that she had other medical issues which may have contributed.
New Zealand health chief, Ashley Bloomfield, said myocarditis was a very rare side effect and there was clear evidence that taking the vaccine was much safer than being infected with COVID-19.
The report comes as the country battles an outbreak of the Delta variant after nearly six months of being virus-free.
Health authorities have so far administered vaccines to more than 2 million people.
The country Prime Minister Jacinda Ardern said Auckland would remain in strict lockdown for at least two more weeks and the rest of the country for at least one more week, but with slightly fewer restrictions, as the nation battles an outbreak of the delta variant.